Sirtuin 3 (SIRT3) regulates mitochondrial antioxidant (AO) defense and improves mitochondrial disorders. Curcumin protects mitochondria; however, the mechanisms need investigation. We postulated that curcumin increases AO defense under hyperglycemic conditions in HepG2 cells through SIRT3-mediated mechanisms. Cell viability was determined in HepG2 cells cultured with 5 mM glucose, 19.9 mM mannitol, vehicle control, 10 mM glucose, and 30 mM glucose in the absence or presence of curcumin for 24 h. SIRT3, nuclear factor-kappa B (NF-κB), heat-shock protein 70 (Hsp70), and Lon protein expressions were determined using western blot. Transcript levels of SIRT3, peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1α), cAMP response element-binding protein (CREB), glutathione peroxidase 1 (GPx1), and superoxide dismutase 2 (SOD2) were measured by quantitative polymerase chain reaction. Cell viability, SIRT3 protein expression, transcript levels of SIRT3, PGC-1α, CREB, GPx1, and SOD2 and protein expressions of NF-κB, Lon, and Hsp70 were significantly increased in the curcumin-treated hyperglycemic groups. Since curcumin and SIRT3 both improve mitochondrial function and AO defense, SIRT3 may be involved in the protective effects of curcumin.
Get full access to this article
View all access options for this article.
References
1.
SchleheJS, LutzAK, PilslA, et al.: Aberrant folding of pathogenic Parkin mutants: Aggregation versus degradation. J Biol Chem, 2008; 283:13771–13779.
2.
WinklhoferKF, TatzeltJ, HaassC: The two faces of protein misfolding: Gain- and loss-of-function in neurodegenerative diseases. EMBO J, 2008; 27:336–349.
AugustyniakA, BartoszG, CipakA, et al.: Natural and synthetic antioxidants: An updated overview. Free Radic Res, 2010; 44:1216–1262.
5.
MunSH, JoungDK, KimYS, et al.: Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus. Phytomedicine, 2013; 20:714–718.
6.
AggarwalBB, HarikumarKB: Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol, 2009; 41:40–59.
7.
AkT, GulcinI: Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact, 2008; 174:27–37.
8.
TrujilloJ, Granados-CastroLF, ZazuetaC, Anderica-RomeroAC, ChirinoYI, Pedraza-ChaverriJ: Mitochondria as a target in the therapeutic properties of curcumin. Arch Pharm, 2014; 347:873–884.
9.
Molina-JijonE, TapiaE, ZazuetaC, et al.: Curcumin prevents Cr(VI)-induced renal oxidant damage by a mitochondrial pathway. Free Radic Biol Med, 2011; 51:1543–1557.
10.
CorreaF, Buelna-ChontalM, Hernandez-ResendizS, et al.: Curcumin maintains cardiac and mitochondrial function in chronic kidney disease. Free Radic Biol Med, 2013; 61:119–129.
11.
ZhangT, WangS, LinY, et al.: Acetylation negatively regulates glycogen phosphorylase by recruiting protein phosphatase 1. Cell Metab, 2012; 15:75–87.
12.
AhnBH, KimHS, SongS, et al.: A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci USA, 2008; 105:14447–14452.
13.
ChenCJ, FuYC, YuW, WangW: SIRT3 protects cardiomyocytes from oxidative stress-mediated cell death by activating NF-kappaB. Biochem Biophys Res Commun, 2013; 430:798–803.
14.
MatsushimaY, GotoY, KaguniLS: Mitochondrial Lon protease regulates mitochondrial DNA copy number and transcription by selective degradation of mitochondrial transcription factor A (TFAM). Proc Natl Acad Sci USA, 2010; 107:18410–18415.
15.
BenderT, LewrenzI, FrankenS, BaitzelC, VoosW: Mitochondrial enzymes are protected from stress-induced aggregation by mitochondrial chaperones and the Pim1/LON protease. Mol Biol Cell, 2011; 22:541–554.
16.
LivakKJ, SchmittgenTD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 2001; 25:402–408.
Madsen-BouterseSA, ZhongQ, MohammadG, HoYS, KowluruRA: Oxidative damage of mitochondrial DNA in diabetes and its protection by manganese superoxide dismutase. Free Radic Res, 2010; 44:313–321.
19.
SzendroediJ, SchmidAI, ChmelikM, et al.: Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med, 2007; 4:e154.
20.
BarzegarA, Moosavi-MovahediAA: Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin. PLoS One, 2011; 6:e26012.
TapiaE, SotoV, Ortiz-VegaKM, et al.: Curcumin induces Nrf2 nuclear translocation and prevents glomerular hypertension, hyperfiltration, oxidant stress, and the decrease in antioxidant enzymes in 5/6 nephrectomized rats. Oxid Med Cell Longev, 2012; 2012:269039.
23.
El-AzabMF, AttiaFM, El-MowafyAM: Novel role of curcumin combined with bone marrow transplantation in reversing experimental diabetes: Effects on pancreatic islet regeneration, oxidative stress, and inflammatory cytokines. Eur J Pharmacol, 2011; 658:41–48.
24.
KuoJJ, ChangHH, TsaiTH, LeeTY: Positive effect of curcumin on inflammation and mitochondrial dysfunction in obese mice with liver steatosis. Int J Mol Med, 2012; 30:673–679.
25.
JanaNR, DikshitP, GoswamiA, NukinaN: Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway. J Biol Chem, 2004; 279:11680–11685.
26.
UgurS, UluR, DogukanA, et al.: The renoprotective effect of curcumin in cisplatin-induced nephrotoxicity. Ren Fail, 2015; 37:332–336.
27.
GoundenS, PhulukdareeA, MoodleyD, ChuturgoonA: Increased SIRT3 expression and antioxidant defense under hyperglycemic conditions in HepG2 cells. Metab Syndr Relat Disord, 2015; 13:255–263.
28.
ZikakiK, AggeliIK, GaitanakiC, BeisI: Curcumin induces the apoptotic intrinsic pathway via upregulation of reactive oxygen species and JNKs in H9c2 cardiac myoblasts. Apoptosis, 2014; 19:958–974.
29.
LundvigDM, PenningsSW, BrouwerKM, et al.: Curcumin induces differential expression of cytoprotective enzymes but similar apoptotic responses in fibroblasts and myofibroblasts. Exp Cell Res, 2015; 330:429–441.
30.
KongX, WangR, XueY, et al.: Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One, 2010; 5:e11707.
NaudiA, JoveM, CacabelosD, et al.: Formation of S-(carboxymethyl)-cysteine in rat liver mitochondrial proteins: Effects of caloric and methionine restriction. Amino acids, 2013; 44:361–371.
33.
RoloAP, PalmeiraCM: Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol, 2006; 212:167–178.
34.
AroorAR, JacksonDE, ShuklaSD: Dysregulated phosphorylation and nuclear translocation of cyclic AMP response element binding protein (CREB) in rat liver after chronic ethanol binge. Eur J Pharmacol, 2012; 679:101–108.
35.
AshabiG, RaminM, AziziP, et al.: ERK and p38 inhibitors attenuate memory deficits and increase CREB phosphorylation and PGC-1alpha levels in Abeta-injected rats. Behav Brain Res, 2012; 232:165–173.
36.
OliveraA, MooreTW, HuF, et al.: Inhibition of the NF-kappaB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): Anti-inflammatory and anti-cancer properties. Int Immunopharmacol, 2012; 12:368–377.
BhakarAL, TannisLL, ZeindlerC, et al.: Constitutive nuclear factor-kappa B activity is required for central neuron survival. J Neurosci, 2002; 22:8466–8475.
41.
FridmacherV, KaltschmidtB, GoudeauB, et al.: Forebrain-specific neuronal inhibition of nuclear factor-kappaB activity leads to loss of neuroprotection. J Neurosci, 2003; 23:9403–9408.
42.
GibelliniL, PintiM, BerettiF, et al.: Sirtuin 3 interacts with Lon protease and regulates its acetylation status. Mitochondrion, 2014; 18:76–81.
43.
PintiM, GibelliniL, De BiasiS, et al.: Functional characterization of the promoter of the human Lon protease gene. Mitochondrion, 2011; 11:200–206.
44.
NgoJK, DaviesKJ: Mitochondrial Lon protease is a human stress protein. Free Radic Biol Med, 2009; 46:1042–1048.
45.
PollaBS, KantengwaS, FrancoisD, et al.: Mitochondria are selective targets for the protective effects of heat shock against oxidative injury. Proc Natl Acad Sci USA, 1996; 93:6458–6463.
